Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics

DOI record: { "DOI": "10.1016/j.ebiom.2022.103856", "ISSN": [ "2352-3964" ], "URL": "http://dx.doi.org/10.1016/j.ebiom.2022.103856", "alternative-id": [ "S2352396422000408" ], "article-number": "103856", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics" }, { "label": "Journal Title", "name": "journaltitle", "value": "eBioMedicine" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ebiom.2022.103856" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 The Authors. Published by Elsevier B.V." } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-3544-4333", "affiliation": [], "authenticated-orcid": false, "family": "Quinn", "given": "Tom M.", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-9295-5503", "affiliation": [], "authenticated-orcid": false, "family": "Gaughan", "given": "Erin E.", "sequence": "additional" }, { "affiliation": [], "family": "Bruce", "given": "Annya", "sequence": "additional" }, { "affiliation": [], "family": "Antonelli", "given": "Jean", "sequence": "additional" }, { "affiliation": [], "family": "O'Connor", "given": "Richard", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Feng", "sequence": "additional" }, { "affiliation": [], "family": "McNamara", "given": "Sarah", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-3454-2855", "affiliation": [], "authenticated-orcid": false, "family": "Koch", "given": "Oliver", "sequence": "additional" }, { "affiliation": [], "family": "MacKintosh", "given": "Claire", "sequence": "additional" }, { "affiliation": [], "family": "Dockrell", "given": "David", "sequence": "additional" }, { "affiliation": [], "family": "Walsh", "given": "Timothy", "sequence": "additional" }, { "affiliation": [], "family": "Blyth", "given": "Kevin G.", "sequence": "additional" }, { "affiliation": [], "family": "Church", "given": "Colin", "sequence": "additional" }, { "affiliation": [], "family": "Schwarze", "given": "Jürgen", "sequence": "additional" }, { "affiliation": [], "family": "Boz", "given": "Cecilia", "sequence": "additional" }, { "affiliation": [], "family": "Valanciute", "given": "Asta", "sequence": "additional" }, { "affiliation": [], "family": "Burgess", "given": "Matthew", "sequence": "additional" }, { "affiliation": [], "family": "Emanuel", "given": "Philip", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-3209-9490", "affiliation": [], "authenticated-orcid": false, "family": "Mills", "given": "Bethany", "sequence": "additional" }, { "affiliation": [], "family": "Rinaldi", "given": "Giulia", "sequence": "additional" }, { "affiliation": [], "family": "Hardisty", "given": "Gareth", "sequence": "additional" }, { "affiliation": [], "family": "Mills", "given": "Ross", "sequence": "additional" }, { "affiliation": [], "family": "Findlay", "given": "Emily Gwyer", "sequence": "additional" }, { "affiliation": [], "family": "Jabbal", "given": "Sunny", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-7767-472X", "affiliation": [], "authenticated-orcid": false, "family": "Duncan", "given": "Andrew", "sequence": "additional" }, { "affiliation": [], "family": "Plant", "given": "Sinéad", "sequence": "additional" }, { "affiliation": [], "family": "Marshall", "given": "Adam D.L.", "sequence": "additional" }, { "affiliation": [], "family": "Young", "given": "Irene", "sequence": "additional" }, { "affiliation": [], "family": "Russell", "given": "Kay", "sequence": "additional" }, { "affiliation": [], "family": "Scholefield", "given": "Emma", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-0576-3387", "affiliation": [], "authenticated-orcid": false, "family": "Nimmo", "given": "Alastair F.", "sequence": "additional" }, { "affiliation": [], "family": "Nazarov", "given": "Islom B.", "sequence": "additional" }, { "affiliation": [], "family": "Churchill", "given": "Grant C.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-4733-1205", "affiliation": [], "authenticated-orcid": false, "family": "McCullagh", "given": "James S.O.", "sequence": "additional" }, { "affiliation": [], "family": "Ebrahimi", "given": "Kourosh H.", "sequence": "additional" }, { "affiliation": [], "family": "Ferrett", "given": "Colin", "sequence": "additional" }, { "affiliation": [], "family": "Templeton", "given": "Kate", "sequence": "additional" }, { "affiliation": [], "family": "Rannard", "given": "Steve", "sequence": "additional" }, { "affiliation": [], "family": "Owen", "given": "Andrew", "sequence": "additional" }, { "affiliation": [], "family": "Moore", "given": "Anne", "sequence": "additional" }, { "affiliation": [], "family": "Finlayson", "given": "Keith", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-5338-2538", "affiliation": [], "authenticated-orcid": false, "family": "Shankar-Hari", "given": "Manu", "sequence": "additional" }, { "affiliation": [], "family": "Norrie", "given": "John", "sequence": "additional" }, { "affiliation": [], "family": "Parker", "given": "Richard A.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-4605-1682", "affiliation": [], "authenticated-orcid": false, "family": "Akram", "given": "Ahsan R.", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-1380-6655", "affiliation": [], "authenticated-orcid": false, "family": "Anthony", "given": "Daniel C.", "sequence": "additional" }, { "affiliation": [], "family": "Dear", "given": "James W.", "sequence": "additional" }, { "affiliation": [], "family": "Hirani", "given": "Nik", "sequence": "additional" }, { "affiliation": [], "family": "Dhaliwal", "given": "Kevin", "sequence": "additional" } ], "container-title": "eBioMedicine", "container-title-short": "eBioMedicine", "content-domain": { "crossmark-restriction": true, "domain": [ "thelancet.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 2, 10 ] ], "date-time": "2022-02-10T23:12:05Z", "timestamp": 1644534725000 }, "deposited": { "date-parts": [ [ 2022, 7, 22 ] ], "date-time": "2022-07-22T07:37:12Z", "timestamp": 1658475432000 }, "indexed": { "date-parts": [ [ 2025, 4, 26 ] ], "date-time": "2025-04-26T13:06:17Z", "timestamp": 1745672777130 }, "is-referenced-by-count": 44, "issued": { "date-parts": [ [ 2022, 2 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 2, 1 ] ], "date-time": "2022-02-01T00:00:00Z", "timestamp": 1643673600000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 1, 18 ] ], "date-time": "2022-01-18T00:00:00Z", "timestamp": 1642464000000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2352396422000408?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2352396422000408?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "103856", "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 2 ] ] }, "published-print": { "date-parts": [ [ 2022, 2 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.ebiom.2022.103856_bib0001", "series-title": "Novel Coronavirus – China", "year": "2020" }, { "DOI": "10.1001/jama.2021.11330", "article-title": "Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis", "author": "Shankar-Hari", "doi-asserted-by": "crossref", "first-page": "499", "issue": "6", "journal-title": "Jama", "key": "10.1016/j.ebiom.2022.103856_bib0002", "volume": "326", "year": "2021" }, { "article-title": "Dexamethasone in hospitalized patients with Covid-19", "author": "Group", "first-page": "693", "issue": "8", "journal-title": "New England Journal of Medicine", "key": "10.1016/j.ebiom.2022.103856_bib0003", "volume": "384", "year": "2020" }, { "DOI": "10.1016/S0140-6736(21)00676-0", "article-title": "Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial", "author": "Abani", "doi-asserted-by": "crossref", "first-page": "1637", "issue": "10285", "journal-title": "The Lancet", "key": "10.1016/j.ebiom.2022.103856_bib0004", "volume": "397", "year": "2021" }, { "DOI": "10.1128/AAC.01043-16", "article-title": "Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay", "author": "Yamamoto", "doi-asserted-by": "crossref", "first-page": "6532", "issue": "11", "journal-title": "Antimicrob Agents Chemother", "key": "10.1016/j.ebiom.2022.103856_bib0005", "volume": "60", "year": "2016" }, { "DOI": "10.3390/v12060629", "article-title": "The anticoagulant nafamostat potently inhibits sars-cov-2 s protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner", "author": "Yamamoto", "doi-asserted-by": "crossref", "first-page": "629", "issue": "6", "journal-title": "Viruses", "key": "10.1016/j.ebiom.2022.103856_bib0006", "volume": "12", "year": "2020" }, { "DOI": "10.1128/AAC.00754-20", "article-title": "Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "e00754", "issue": "6", "journal-title": "Antimicrobial Agents and Chemotherapy", "key": "10.1016/j.ebiom.2022.103856_bib0007", "volume": "64", "year": "2020" }, { "DOI": "10.1128/mBio.00970-21", "article-title": "The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19", "author": "Li", "doi-asserted-by": "crossref", "journal-title": "mBio", "key": "10.1016/j.ebiom.2022.103856_bib0008", "year": "2021" }, { "DOI": "10.1097/MD.0000000000002392", "article-title": "Nafamostat mesilate as an anticoagulant during continuous renal replacement therapy in patients with high bleeding risk: a randomized clinical trial", "author": "Choi", "doi-asserted-by": "crossref", "first-page": "e2392", "issue": "52", "journal-title": "Medicine (Baltimore)", "key": "10.1016/j.ebiom.2022.103856_bib0009", "volume": "94", "year": "2015" }, { "DOI": "10.1111/j.1527-3466.1995.tb00213.x", "author": "Okajima", "doi-asserted-by": "crossref", "first-page": "51", "issue": "1", "journal-title": "Cardiovascular Drug Reviews", "key": "10.1016/j.ebiom.2022.103856_bib0010", "volume": "13", "year": "1995" }, { "DOI": "10.1254/jjp.35.203", "article-title": "Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments", "author": "Aoyama", "doi-asserted-by": "crossref", "first-page": "203", "issue": "3", "journal-title": "Jpn J Pharmacol", "key": "10.1016/j.ebiom.2022.103856_bib0011", "volume": "35", "year": "1984" }, { "DOI": "10.1016/0005-2744(81)90023-1", "article-title": "New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsin", "author": "Fujii", "doi-asserted-by": "crossref", "first-page": "342", "issue": "2", "journal-title": "Biochimica et Biophysica Acta (BBA) - Enzymology", "key": "10.1016/j.ebiom.2022.103856_bib0012", "volume": "661", "year": "1981" }, { "article-title": "DEFINE: a phase iia randomised controlled trial to evaluate repurposed treatments for COVID-19", "author": "Gaughan", "journal-title": "medRxiv", "key": "10.1016/j.ebiom.2022.103856_bib0013", "year": "2021" }, { "DOI": "10.1002/ajh.23599", "article-title": "TEG and ROTEM: Technology and clinical applications", "author": "Whiting", "doi-asserted-by": "crossref", "first-page": "228", "issue": "2", "journal-title": "American Journal of Hematology", "key": "10.1016/j.ebiom.2022.103856_bib0014", "volume": "89", "year": "2014" }, { "DOI": "10.1007/s11239-020-02272-8", "article-title": "Functional testing of tranexamic acid effects in patients undergoing elective orthopaedic surgery", "author": "Groene", "doi-asserted-by": "crossref", "first-page": "989", "issue": "4", "journal-title": "J Thromb Thrombolysis", "key": "10.1016/j.ebiom.2022.103856_bib0015", "volume": "51", "year": "2021" }, { "DOI": "10.1159/000511230", "article-title": "Functional testing for tranexamic acid duration of action using modified viscoelastometry", "author": "Kammerer", "doi-asserted-by": "crossref", "first-page": "109", "issue": "2", "journal-title": "Transfusion Medicine and Hemotherapy", "key": "10.1016/j.ebiom.2022.103856_bib0016", "volume": "48", "year": "2021" }, { "author": "McCullagh", "key": "10.1016/j.ebiom.2022.103856_bib0017", "series-title": "Generalized Linear Models", "year": "1983" }, { "DOI": "10.1002/jmv.26397", "article-title": "Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells", "author": "Ko", "doi-asserted-by": "crossref", "first-page": "1403", "issue": "3", "journal-title": "Journal of Medical Virology", "key": "10.1016/j.ebiom.2022.103856_bib0018", "volume": "93", "year": "2021" }, { "DOI": "10.1016/j.ijid.2020.05.072", "article-title": "Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy", "author": "Jang", "doi-asserted-by": "crossref", "first-page": "500", "journal-title": "Int J Infect Dis", "key": "10.1016/j.ebiom.2022.103856_bib0019", "volume": "96", "year": "2020" }, { "DOI": "10.1186/s13054-020-03078-z", "article-title": "Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series", "author": "Doi", "doi-asserted-by": "crossref", "first-page": "392", "issue": "1", "journal-title": "Critical Care", "key": "10.1016/j.ebiom.2022.103856_bib0020", "volume": "24", "year": "2020" }, { "key": "10.1016/j.ebiom.2022.103856_bib0021", "unstructured": "EUnetHTA Joint Action 3 WP4: NAFAMOSTAT FOR THE TREATMENT OF COVID-19. Version 7.0, May 2021" }, { "DOI": "10.1016/0306-3623(95)00072-0", "article-title": "Mechanisms of hyperkalemia caused by nafamostat mesilate", "author": "Muto", "doi-asserted-by": "crossref", "first-page": "1627", "issue": "8", "journal-title": "Gen Pharmacol", "key": "10.1016/j.ebiom.2022.103856_bib0022", "volume": "26", "year": "1995" }, { "DOI": "10.1007/s00216-008-2054-4", "article-title": "A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study", "author": "Cao", "doi-asserted-by": "crossref", "first-page": "1063", "issue": "3", "journal-title": "Anal Bioanal Chem", "key": "10.1016/j.ebiom.2022.103856_bib0023", "volume": "391", "year": "2008" }, { "DOI": "10.2133/dmpk.21.147", "article-title": "Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis", "author": "Yamaori", "doi-asserted-by": "crossref", "first-page": "147", "issue": "2", "journal-title": "Drug Metabolism and Pharmacokinetics", "key": "10.1016/j.ebiom.2022.103856_bib0024", "volume": "21", "year": "2006" }, { "DOI": "10.2174/1389200219666180821094502", "article-title": "The impact of carboxylesterases in drug metabolism and pharmacokinetics", "author": "Di", "doi-asserted-by": "crossref", "first-page": "91", "issue": "2", "journal-title": "Curr Drug Metab", "key": "10.1016/j.ebiom.2022.103856_bib0025", "volume": "20", "year": "2019" }, { "key": "10.1016/j.ebiom.2022.103856_bib0026", "unstructured": "group TLdi. COVID-19 Drug interactions, 2021 [accessed 5/8/21.2021]." }, { "DOI": "10.1111/jth.14830", "article-title": "Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia", "author": "Cui", "doi-asserted-by": "crossref", "first-page": "1421", "issue": "6", "journal-title": "Journal of Thrombosis and Haemostasis", "key": "10.1016/j.ebiom.2022.103856_bib0027", "volume": "18", "year": "2020" }, { "article-title": "The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes", "author": "Malato", "first-page": "559", "issue": "4", "journal-title": "Blood Transfus", "key": "10.1016/j.ebiom.2022.103856_bib0028", "volume": "13", "year": "2015" }, { "DOI": "10.1111/jth.14768", "article-title": "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia", "author": "Tang", "doi-asserted-by": "crossref", "first-page": "844", "issue": "4", "journal-title": "Journal of Thrombosis and Haemostasis", "key": "10.1016/j.ebiom.2022.103856_bib0029", "volume": "18", "year": "2020" }, { "DOI": "10.1016/S2352-3026(20)30145-9", "article-title": "Coagulation abnormalities and thrombosis in patients with COVID-19", "author": "Levi", "doi-asserted-by": "crossref", "first-page": "e438", "issue": "6", "journal-title": "Lancet Haematol", "key": "10.1016/j.ebiom.2022.103856_bib0030", "volume": "7", "year": "2020" }, { "DOI": "10.1097/CCM.0000000000004471", "article-title": "Thromboelastography profiles of critically Ill patients with coronavirus disease 2019", "author": "Yuriditsky", "doi-asserted-by": "crossref", "first-page": "1319", "issue": "9", "journal-title": "Crit Care Med", "key": "10.1016/j.ebiom.2022.103856_bib0031", "volume": "48", "year": "2020" }, { "DOI": "10.1126/science.abc8511", "article-title": "Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications", "author": "Mathew", "doi-asserted-by": "crossref", "first-page": "eabc8511", "issue": "6508", "journal-title": "Science", "key": "10.1016/j.ebiom.2022.103856_bib0032", "volume": "369", "year": "2020" }, { "DOI": "10.1126/sciimmunol.abd7114", "article-title": "Comprehensive mapping of immune perturbations associated with severe COVID-19", "author": "Kuri-Cervantes", "doi-asserted-by": "crossref", "first-page": "eabd7114", "issue": "49", "journal-title": "Science Immunology", "key": "10.1016/j.ebiom.2022.103856_bib0033", "volume": "5", "year": "2020" }, { "article-title": "Evaluation of nafamostat mesylate safety and inhibition of SARS-CoV-2 replication using a 3-dimensional human airway epithelia model", "author": "Kirkpatrick", "journal-title": "bioRxiv", "key": "10.1016/j.ebiom.2022.103856_bib0034", "year": "2020" }, { "article-title": "SARS-CoV-2 Spreads through cell-to-cell transmission", "author": "Zeng", "journal-title": "bioRxiv", "key": "10.1016/j.ebiom.2022.103856_bib0035", "year": "2021" } ], "reference-count": 35, "references-count": 35, "relation": { "has-preprint": [ { "asserted-by": "object", "id": "10.1101/2021.10.06.21264648", "id-type": "doi" } ] }, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2352396422000408" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "76" }